Canada Reaches Agreement With J&J for COVID-19 Vaccine Doses

Johnson & Johnson has reached an agreement in principle with Canada to supply the country with 38 million doses of its COVID-19 vaccine Ad26.COV2.S.

Canada will purchase the doses from J&J on a not-for-profit basis for emergency pandemic use, subject to the vaccine’s approval by Health Canada.

Canada has also secured advanced COVID-19 vaccine supply deals with Novavax, Pfizer and Moderna.